| Phage therapy in clinical practice: treatment of human infections E Kutter, D De Vos, G Gvasalia, Z Alavidze, L Gogokhia, S Kuhl, ... Current pharmaceutical biotechnology 11 (1), 69-86, 2010 | 851 | 2010 |
| Expansion of bacteriophages is linked to aggravated intestinal inflammation and colitis L Gogokhia, K Buhrke, R Bell, B Hoffman, DG Brown, C Hanke-Gogokhia, ... Cell host & microbe 25 (2), 285-299. e8, 2019 | 430 | 2019 |
| Chronic wounds and the medical biofilm paradigm RD Wolcott, DD Rhoads, ME Bennett, BM Wolcott, L Gogokhia, ... Journal of wound care 19 (2), 45-53, 2010 | 411 | 2010 |
| A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice TR Chiaro, R Soto, W Zac Stephens, JL Kubinak, C Petersen, L Gogokhia, ... Science translational medicine 9 (380), eaaf9044, 2017 | 202 | 2017 |
| MHC variation sculpts individualized microbial communities that control susceptibility to enteric infection JL Kubinak, WZ Stephens, R Soto, C Petersen, T Chiaro, L Gogokhia, ... Nature communications 6 (1), 8642, 2015 | 171 | 2015 |
| Transferable immunoglobulin A–Coated Odoribacter splanchnicus in responders to fecal microbiota transplantation for ulcerative colitis limits colonic inflammation SF Lima, L Gogokhia, M Viladomiu, L Chou, G Putzel, WB Jin, S Pires, ... Gastroenterology 162 (1), 166-178, 2022 | 74 | 2022 |
| Current updates from the long-standing phage research centers in Georgia, Poland, and Russia R Międzybrodzki, N Hoyle, F Zhvaniya, M Łusiak-Szelachowska, ... Bacteriophages: biology, technology, therapy, 921-951, 2021 | 45 | 2021 |
| The tip of the tail needle affects the rate of DNA delivery by bacteriophage P22 JC Leavitt, L Gogokhia, EB Gilcrease, A Bhardwaj, G Cingolani, ... PloS one 8 (8), e70936, 2013 | 34 | 2013 |
| Immune–bacteriophage interactions in inflammatory bowel diseases L Gogokhia, JL Round Current opinion in virology 49, 30-35, 2021 | 21 | 2021 |
| Soluble β-N-acetylglucosaminidase based antibiofilm compositions and uses thereof S Madhyastha, N Yakandawala, PV Gawande, K LoVetri, JB Kaplan, ... US Patent 8,821,862, 2014 | 19 | 2014 |
| Intestinal dysbiosis and markers of systemic inflammation in viscerally and generally obese persons living with HIV L Gogokhia, Y Taur, K Juluru, N Yagan, YS Zhu, E Pamer, MJ Glesby JAIDS Journal of Acquired Immune Deficiency Syndromes 83 (1), 81-89, 2020 | 16 | 2020 |
| Souluble bn-acetylglucoseaminidase based antibiofilm compositions and uses thereof S Madhyastha, N Yakandawala, PV Gawande, K LoVetri, JB Kaplan, ... US Patent App. 12/445,403, 2011 | 12 | 2011 |
| 1130–Transferable Iga-Reactive Microbiota Stratify Clinical Response to Fmt for Ulcerative Colitis L Gogokhia, CV Crawford, SF Lima, M Viladomiu, V Jacob, E Scherl, ... Gastroenterology 156 (6), S-239, 2019 | 2 | 2019 |
| Dietary fiber is a critical determinant of pathologic ILC2 responses and intestinal inflammation M Arifuzzaman, TH Won, H Yano, J Uddin, ER Emanuel, E Hu, W Zhang, ... Journal of Experimental Medicine 221 (5), 2024 | 1 | 2024 |
| Trends in medicare spending and utilization of oral medications for Clostridioides difficile infection from 2013 to 2021 X Ying, L Gogokhia, AB Jesudian, L Zhang, CV Crawford Gastro Hep Advances 3 (2), 210-211, 2024 | 1 | 2024 |
| P076 transferable immune reactive microbiota determine clinical and immunologic outcome of fecal microbiota transplantation for ulcerative colitis S Lima, L Gogokhia, M Viladomiu, C Crawford, V Jacob, E Scherl, ... Gastroenterology 158 (3), S63-S64, 2020 | 1 | 2020 |
| OP40 A core transferable microbiota in responders to faecal microbiota transplant for ulcerative colitis shape mucosal T-cell immunity L Gogokhia, S Lima, M Viladomiu, Y Gerardin, C Crawford, V Jacob, ... Journal of Crohn's and Colitis 14 (Supplement_1), S040-S041, 2020 | 1 | 2020 |
| Tu1002 COVERAGE OF CLOSTRIDIOIDES DIFFICILE ANTIBIOTICS IN MEDICARE: 2015 TO 2023 E Reznik, X Ying, L Gogokhia, A Jesudian, CV Crawford Gastroenterology 166 (5), S-1214, 2024 | | 2024 |
| Su1782 A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF PSYLLIUM FIBER AND FECAL FECAL MICROBIOTA TRANSPLANTATION FOR MILD TO MODERATE ULCERATIVE COLITIS L Gogokhia, N Tran, A Lavergne, G Funez-dePagnier, G Xiang, R Warren, ... Gastroenterology 166 (5), S-811, 2024 | | 2024 |
| A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF PSYLLIUM FIBER AND FECAL MICROBIOTA TRANSPLANTATION FOR MILD TO MODERATE ULCERATIVE COLITIS L Gogokhia, N Tran, A Lavergne, G Funez-dePagnier, G Xiang, R Warren, ... Gastroenterology 166 (3), S11, 2024 | | 2024 |
